| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nathan Gilbreth, Hari Nath, Fernando Quesada, Delatre Lol. Clozapine-Induced Pericardial Effusion Presenting with Persistent Tachycardia. Case reports in medicine. vol 2021. 2021-09-10. PMID:34497649. |
clozapine is an atypical antipsychotic used in refractory schizophrenia and depression. |
2021-09-10 |
2023-08-13 |
Not clear |
| Marek Krzystanek, Marek Asman, Joanna Witecka, Artur Pałasz, Ryszard Wiaderkiewic. Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study. Pharmacological reports : PR. vol 73. issue 1. 2021-09-08. PMID:33025395. |
selected single-nucleotide variants in grin1, grin2a, and grin2b encoding subunits of the nmda receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study. |
2021-09-08 |
2023-08-13 |
Not clear |
| Graham Blackman, Jenny E L Lisshammar, Rayyan Zafar, Thomas A Pollak, Megan Pritchard, Alexis E Cullen, Jonathan Rogers, Ben Carter, Kira Griffiths, Matthew Nour, Anthony S David, Philip McGuire, Robert Stewart, James MacCab. Clozapine Response in Schizophrenia and Hematological Changes. Journal of clinical psychopharmacology. vol 41. issue 1. 2021-09-07. PMID:33347018. |
clozapine response in schizophrenia and hematological changes. |
2021-09-07 |
2023-08-13 |
Not clear |
| Graham Blackman, Jenny E L Lisshammar, Rayyan Zafar, Thomas A Pollak, Megan Pritchard, Alexis E Cullen, Jonathan Rogers, Ben Carter, Kira Griffiths, Matthew Nour, Anthony S David, Philip McGuire, Robert Stewart, James MacCab. Clozapine Response in Schizophrenia and Hematological Changes. Journal of clinical psychopharmacology. vol 41. issue 1. 2021-09-07. PMID:33347018. |
clozapine is the only effective medication for treatment-resistant schizophrenia; however, its mechanism of action remains unclear. |
2021-09-07 |
2023-08-13 |
Not clear |
| Meha Verma, Sandeep Grover, Subho Chakrabart. Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics. Journal of clinical psychopharmacology. vol 41. issue 1. 2021-09-07. PMID:33347021. |
cost of the illness of treatment-resistant schizophrenia: a mirror image study comparing clozapine with other antipsychotics. |
2021-09-07 |
2023-08-13 |
Not clear |
| Meha Verma, Sandeep Grover, Subho Chakrabart. Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics. Journal of clinical psychopharmacology. vol 41. issue 1. 2021-09-07. PMID:33347021. |
this study aimed to evaluate and compare the cost of illness in patients with treatment-resistant schizophrenia (trs) during 3 months before starting clozapine and for the initial 3 months of treatment with clozapine. |
2021-09-07 |
2023-08-13 |
Not clear |
| Michael Shuman, Lori Moss, Adam Dilic. Never Say Never: Successful Clozapine Rechallenge After Multiple Episodes of Neutropenia. Focus (American Psychiatric Publishing). vol 19. issue 1. 2021-09-07. PMID:34483771. |
clozapine is a second-generation antipsychotic with a superior efficacy for the management of treatment-resistant schizophrenia but underutilized because of potential side effects. |
2021-09-07 |
2023-08-13 |
Not clear |
| Olaoluwa O Okusaga, Brian G Mitchell, Jared D Bernard, Annette Walde. Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia or Schizoaffective Disorder. The Journal of clinical psychiatry. vol 82. issue 5. 2021-09-02. PMID:34428355. |
clozapine is associated with higher covid-19 infection rate in veterans with schizophrenia or schizoaffective disorder. |
2021-09-02 |
2023-08-13 |
Not clear |
| Sarah L Kopelovich, Keith Wood, Robert O Cotes, David R Goldsmit. Integration of Clozapine-associated Harm Obsessions into Cognitive Behavioral Conceptualization and Treatment Planning for Thought Broadcasting: A Case Study. Journal of psychiatric practice. vol 26. issue 4. 2021-09-01. PMID:32692132. |
clozapine has demonstrated superior efficacy for the treatment of medication-resistant schizophrenia but it is also associated with an increased risk for ocs. |
2021-09-01 |
2023-08-13 |
Not clear |
| Giulia Tronchin, Theophilus N Akudjedu, Mohamed Ahmed, Laurena Holleran, Brian Hallahan, Dara M Cannon, Colm McDonal. Correction to: Progressive subcortical volume loss in treatment-resistant schizophrenia patients after commencing clozapine treatment. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 46. issue 10. 2021-09-01. PMID:34168280. |
correction to: progressive subcortical volume loss in treatment-resistant schizophrenia patients after commencing clozapine treatment. |
2021-09-01 |
2023-08-13 |
Not clear |
| Seong Hoon Jeong, Yong Sik Ki. Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 19. issue 3. 2021-09-01. PMID:34294611. |
schizophrenia has been considered to have a deep connection with the immune system, and clozapine can induce further changes in this system. |
2021-09-01 |
2023-08-13 |
Not clear |
| Selene R T Veerman, Jan P A M Bogers, Dan Cohen, Peter F J Schult. COVID-19: Risks, Complications, and Monitoring in Patients on Clozapine. Pharmacopsychiatry. 2021-09-01. PMID:34470068. |
schizophrenia patients in general and clozapine users in particular belong to a high-risk group that warrants early vaccination on a medical indication. |
2021-09-01 |
2023-08-13 |
Not clear |
| Pasquale Paribello, Mirko Manchia, Massimo Zedda, Federica Pinna, Bernardo Carpiniell. Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature. Medicina (Kaunas, Lithuania). vol 57. issue 8. 2021-08-31. PMID:34441022. |
clozapine is the only antipsychotic approved for treatment-resistant schizophrenia. |
2021-08-31 |
2023-08-13 |
Not clear |
| Orwa Albitar, Sabariah Noor Harun, Siti Nor Aizah Ahmad, Siti Maisharah Sheikh Ghadz. A Repeated Time-to-Positive Symptoms Improvement among Malaysian Patients with Schizophrenia Spectrum Disorders Treated with Clozapine. Pharmaceutics. vol 13. issue 8. 2021-08-31. PMID:34452082. |
clozapine remains the drug of choice for resistant schizophrenia. |
2021-08-31 |
2023-08-13 |
Not clear |
| Hindol Mukherjee, Vladimir Sazhi. Predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2021-08-31. PMID:34464166. |
predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. |
2021-08-31 |
2023-08-13 |
Not clear |
| Hindol Mukherjee, Vladimir Sazhi. Predictors of functioning and clinical outcomes in inpatient with schizophrenia on clozapine augmented with antipsychotics. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 2021-08-31. PMID:34464166. |
we aimed at exploring predictors of improvement in clinical and functional outcomes of patients on clozapine with chronic treatment-resistant schizophrenia admitted into rehabilitation wards. |
2021-08-31 |
2023-08-13 |
Not clear |
| Sho Fujimoto, Naoyasu Ueda, Naoya Nishimura, Atsushi Naito, Junki Hiura, Kouichi Mashiba, Ayane Ikai, Kousuke Marutsuka, Kentaro Mizun. Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report. Modern rheumatology case reports. vol 4. issue 1. 2021-08-25. PMID:33086971. |
herein, we report a case of a 48-year-old japanese woman with schizophrenia who presented with fever, arthralgia, myalgia and skin rash after 2 years of clozapine treatment. |
2021-08-25 |
2023-08-13 |
Not clear |
| Brandi L Bellissima, Alisha Vara, Nuala Helsby, Fintan Garavan, Malcolm D Tingl. Incidence and investigation of potential risk-factors for clozapine-associated myocarditis and cardiomyopathy in a New Zealand cohort. Psychiatry research. vol 299. 2021-08-25. PMID:33799127. |
clozapine is a uniquely effective antipsychotic indicated for treatment-resistant schizophrenia. |
2021-08-25 |
2023-08-13 |
Not clear |
| Shinichi Imazu, Takeo Hata, Katsunori Toyoda, Yoichiro Kubo, Shigeru Yamauchi, Shinya Kinoshita, Masami Nishihara, Ken Inada, Tetsufumi Kanazaw. Safety profile of clozapine: Analysis using national registry data in Japan. Journal of psychiatric research. vol 141. 2021-08-25. PMID:34192602. |
clozapine is the only effective antipsychotic drug used for the treatment of treatment-resistant schizophrenia. |
2021-08-25 |
2023-08-13 |
Not clear |
| Young Tak Jo, Sung Woo Joo, Soojin Ahn, Youngjae Choi, Jungsun Le. Use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. BJPsych open. vol 7. issue 5. 2021-08-21. PMID:34342261. |
use of olanzapine compared with clozapine for treatment-resistant schizophrenia in a real-world setting: nationwide register-based study. |
2021-08-21 |
2023-08-13 |
Not clear |